Portfolio
Corner Office
Culture
Premium
Opinion
Events
Market Intelligence
Innovation
Subscribe
Sign In
Register
Menu
Subscribe
Sign In
Register
Portfolio
Corner Office
Culture
Premium
Opinion
Events
Market Intelligence
Innovation
Subscribe
Sign In
Register
Search Query
Submit Search
Show Search
Hedge Funds
Premium
The Funds Reeling from the Disastrous Drop in Health Care and Biopharma
Most life sciences hedge funds, including Casdin Capital and Cormorant, are sinking deeper into the red.
Stephen Taub
April 15, 2025 03:23 AM
Hedge Funds
Tiger Funds Shield Investors From (Some) Market Turmoil
April 14, 2025
Premium
Robert Citrone, Who Has Been a Bear for Months, Expects ‘Shallow’ Recession
Stephen Taub
April 10, 2025
Corner Office
Facing Anti-Trans Policies, Top Performing Manager Contemplates Move to Canada
Michelle Celarier
April 9, 2025
Hedge Funds
Experts Have Little Hope for a Revival of Hedge Fund Investments in Private Markets
Stephen Taub
April 8, 2025
Premium
Third Point Hit Hard by New Bet on Carvana
Stephen Taub
April 7, 2025
Hedge Funds
Valiant’s Short Book Drove the Tiger Grandcub to a Profitable Q1
Stephen Taub
April 3, 2025
Premium
The Returns of Hedge Funds’ Favorite Stocks Are Not Signaling ‘Portfolio Protection’
Stephen Taub
April 2, 2025
Premium
A Much-Anticipated Tech IPO Is a Dud
Stephen Taub
March 31, 2025
Premium
Volatile Haidar Is Bullish Now
Stephen Taub
March 27, 2025
Premium
Seligman Slashes Market Exposure
Stephen Taub
March 26, 2025